mannose has been researched along with HPV Infection in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, W; Wang, Z; Wei, C; Xiao, G; Zhang, Y; Zhou, Z | 1 |
Hirohashi, Y; Kuroda, T; Mizuuchi, M; Saito, T; Sato, N; Shimizu, Y; Torigoe, T; Yasuda, K | 1 |
Dyer, J; Fujita, Y; Ho, MF; Moyle, PM; Olive, C; Pandey, M; Suhrbier, A; Toth, I | 1 |
3 other study(ies) available for mannose and HPV Infection
Article | Year |
---|---|
Fungal mannosylation enhances human papillomavirus 16 E7 therapeutic immunity against TC-1 tumors.
Topics: Animals; Cancer Vaccines; Dendritic Cells; Female; Human papillomavirus 16; Humans; Immunization; Interferon-gamma; Mannose; Mice; Mice, Inbred C57BL; Papillomavirus E7 Proteins; Papillomavirus Infections; Pichia; Protein Engineering; Respiratory Tract Neoplasms; Xenograft Model Antitumor Assays | 2018 |
Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responses.
Topics: Adult; DNA, Viral; Female; Genotype; HLA-A24 Antigen; Humans; Liposomes; Lymphocyte Activation; Mannose; Middle Aged; Oligosaccharides; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus E7 Proteins; Papillomavirus Infections; Plasmids; Repressor Proteins; T-Lymphocytes, Cytotoxic; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaccination; Vaccines, DNA | 2012 |
Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines.
Topics: Animals; Cancer Vaccines; Dendritic Cells; Epitopes; Female; Glucose; Human papillomavirus 16; Lectins, C-Type; Lipoproteins; Mannose; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Papillomavirus Infections; Papillomavirus Vaccines; Peptide Fragments; Peptides; Receptors, Cell Surface; Transplantation, Heterologous; Uterine Cervical Neoplasms; Vaccines, Synthetic | 2007 |